| 摘要 |
IL-17B is known to stimulate the proliferation of chondrocytes, bone, and is highly expressed in nervous tissue, resulting in repair of diseased tiss ue. When IL-17B is absent a marked negative effect on wound healing is noted . The present invention comprises providing IL-17B, by topical, parental, or other administration means, in order to accelerate the wound healing proces s. The present invention further encompasses a pharmaceutical composition an d formulations thereof that utilize IL-17B, either alone or in combination w ith other cytokines or growth factors known to aid wound healing. The invent ion also contemplates methods of treating wounds in patients using this phar maceutical composition. |
